Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Regional therapy of melanoma.
Lejeune FJ, Liénard D, Leyvraz S, Mirimanoff RO. Lejeune FJ, et al. Among authors: lienard d. Eur J Cancer. 1993;29A(4):606-12. doi: 10.1016/s0959-8049(05)80163-7. Eur J Cancer. 1993. PMID: 8435217 Review.
[Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience].
Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Schmitz P. Lejeune F, et al. Among authors: lienard d. Bull Cancer. 1995 Jul;82(7):561-7. Bull Cancer. 1995. PMID: 7549119 French.
Soft tissue sarcoma therapy: prospects for future studies.
Lejeune FJ, Liénard D, Rüegg C, Leyvraz S. Lejeune FJ, et al. Among authors: lienard d. Eur J Surg Oncol. 1995 Oct;21(5):474-7. doi: 10.1016/s0748-7983(95)96713-3. Eur J Surg Oncol. 1995. PMID: 7589588 Review. No abstract available.
Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.
Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J, Schmitz P. Lejeune F, et al. Among authors: lienard d. J Cell Biochem. 1994 Sep;56(1):52-61. doi: 10.1002/jcb.240560110. J Cell Biochem. 1994. PMID: 7806592 Review.
Clinical applications of TNF-alpha in cancer.
Lejeune FJ, Rüegg C, Liénard D. Lejeune FJ, et al. Among authors: lienard d. Curr Opin Immunol. 1998 Oct;10(5):573-80. doi: 10.1016/s0952-7915(98)80226-4. Curr Opin Immunol. 1998. PMID: 9794839 Review.
Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.
Liénard D, Eggermont AM, Koops HS, Kroon B, Towse G, Hiemstra S, Schmitz P, Clarke J, Steinmann G, Rosenkaimer F, Lejeune FJ. Liénard D, et al. Melanoma Res. 1999 Oct;9(5):491-502. doi: 10.1097/00008390-199910000-00009. Melanoma Res. 1999. PMID: 10596916 Clinical Trial.
154 results